Last Week in Cannabis #17
September 21–27, 2026 | Issue #17
Hey friend — welcome back to Last Week in Cannabis. The Aurora-Curaleaf saga took a significant new turn this week, Health Canada opened a new consultation that could mean less red tape for the industry, and a big vote south of the border next month could make history. Let's get into it.
1. CANADA — Aurora Takes Curaleaf to the Securities Commission
The Aurora-Curaleaf takeover story has been running for weeks, and this week it escalated meaningfully. Aurora Cannabis filed a formal application with the Alberta Securities Commission on September 23rd, asking the regulator to order Curaleaf to fix what Aurora says are material deficiencies in its hostile bid circular — including missing pro-forma financial statements, failure to observe the mandatory 105-day deposit period, and an absent French-language notice required in Quebec.
Aurora's board and special committee unanimously reiterated their recommendation that shareholders take no action and reject the bid. Curaleaf, for its part, had previously filed its own application asking the ASC to block Aurora from issuing new shares while the bid is outstanding — a move Aurora called a distraction.
Mary Jane's Take: Taking your hostile bidder to the securities regulator is a significant escalation. What Aurora is arguing, in plain terms, is that Curaleaf's bid materials do not meet the legal standards that protect shareholders' ability to make an informed decision. Whether the ASC agrees will determine whether this bid stays alive in its current form or gets sent back for revisions. Either way, this story is not resolving quietly. Aurora's global medical cannabis platform is a genuinely valuable asset, and both companies clearly know it.
2. CANADA — Health Canada Is Proposing to Cut Red Tape on Cannabis Tracking
Health Canada opened a new public consultation on September 26th, proposing amendments to the Cannabis Tracking System Order that would reduce reporting requirements for federally licensed producers. Under the proposed changes, licence holders would no longer need to report book value and site capacity information, and several inventory reporting categories would be consolidated. The consultation period runs until November 10, 2026.
Perhaps most significantly, the proposed amendments would eliminate federal tracking reporting requirements for provincially authorized distributors and retailers altogether — without changing any provincial requirements that already exist.
Mary Jane's Take: The Cannabis Tracking System was built when legalization was new and regulators needed visibility into every corner of a brand new industry. Eight years in, the market is mature, and some of that reporting burden has become administrative overhead rather than genuine oversight. Reducing reporting requirements for retailers and distributors while keeping core supply chain tracking in place is a sensible evolution. If you are a licence holder or work in the industry, this consultation is worth engaging with — November 10th is the deadline.
3. CANADA — A New Study Found More Legal Cannabis Stores Does Not Mean More Teen Use
A study published this week added to a growing body of research finding that increased retail availability of legal cannabis does not translate directly into higher rates of youth use. Evidence from Canada indicates that adolescent cannabis use has remained relatively stable following legalization, despite a substantial expansion in the number of retail stores across the country.
Mary Jane's Take: This is an important piece of the legalization story that deserves more attention than it typically gets. The intuitive assumption is that more stores equals more access for young people. The data from Canada's own experience keeps showing that is not how it works in practice. Age verification, a shift in the social meaning of cannabis, and a reduction in the forbidden-fruit effect all appear to matter more than the number of storefronts. That does not mean youth protection should be taken for granted — it means the mechanisms that protect young people in a regulated market are working, and should be maintained.
4. UNITED STATES — Massachusetts Voters Are About to Make History — One Way or Another
In November, Massachusetts voters will decide on Question 8 — a ballot measure that would repeal the state's adult-use cannabis legalization laws, eliminating licensed retail sales, commercial production, and the right to grow cannabis at home. Medical cannabis and limited adult possession would remain legal. If it passes, Massachusetts would become the first state in history to dismantle its recreational cannabis market through a popular vote.
Current polling shows roughly 55% of registered voters opposed to the repeal and 33% in favour — a margin that sounds comfortable but is not decisive enough to guarantee the outcome. More than 8,000 people showed up at the Boston Common last weekend to rally against the repeal. The campaign to protect legalization has raised $6.7 million, compared to $4.2 million raised by repeal advocates.
Mary Jane's Take: This is one of the most consequential cannabis votes anywhere in the world this year. Voters in Massachusetts approved legalization with a 54% majority in 2016 — almost a decade ago. Question 8 would undo that in a single ballot. The polling looks favourable for legalization, but cannabis advocates know better than to count anything as settled before election night. The November 3rd vote is worth watching closely regardless of where you live, because the result will send a message that reverberates far beyond Massachusetts.
That's your week — three from Canada, one from the United States. See you next Monday.
— Mary Jane
